Drug intelligence / Profile preview

Oxycelanim

Development stage
Unknown
Lead developer
Research Institute for Physical and Chemical Problems of the Belarusian State University
Modality
Small Molecules, Peptides
Administration
Implant, Topical
01

Overview

**Oxycelanim** is a Belarusian bioresorbable medicated wound dressing supplied as a knitted cellulose wipe for topical and implantation use. It consists of oxidized cellulose containing immobilized **gentamicin** and the synthetic immunomodulatory peptide **thymogen**. Oxidized cellulose provides local hemostatic activity, while gentamicin supplies prolonged local aminoglycoside antibacterial activity through inhibition of bacterial protein synthesis and thymogen is intended to stimulate cellular and humoral immune responses. It is indicated for purulent-inflammatory diseases of the skin, soft tissues, and mucous membranes, including infected wounds, trophic ulcers, furuncles, abscesses, carbuncles, paraproctitis, thermal burns, phlegmons, hidradenitis, and lymphadenitis, and may be implanted to help prevent postoperative purulent-septic complications. The originating institute reports a Belarusian registration certificate, and published work describes the product as intended for clinical use and industrial production. ([apteka.103.by](https://apteka.103.by/oksicelanim-instruktsiya/))

Brand names
Oxycelanim
Other names
oksitselanimОксицеланим
02

Targets

Bacterial Ribosome

Beyond the preview

Go deeper on Oxycelanim.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oxycelanim.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call